Inovio pharmaceuticals stock.

See why we are neutral on INO stock. ... Jun. 27, 2023 7:15 AM ET Inovio Pharmaceuticals, Inc. (INO) 11 Comments 3 Likes. Out of Ignorance. 7.05K Followers. Follow. Summary.Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA ...Important Documents. There are no documents available for this stock. Recent dividends ...Feb 16, 2023 · Inovio Pharmaceuticals, Inc. 0.4014-0.0086 ... A stock sale "will shine a spotlight on the business model and financials" of the fast-fashion giant about which little is known, said one analyst. ...

The latest closing stock price for Inovio Pharmaceuticals as of November 17, 2023 is 0.43. The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000. The Inovio Pharmaceuticals 52-week high stock price is 2.17, which is 404.7% above the current share price. The Inovio Pharmaceuticals 52-week low stock price is …Inovio Pharmaceuticals (INO 2.77%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ...

Jun 27, 2022 · Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company. Inovio Pharmaceuticals, Inc. Common Stock (INO) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask refers to the price that an...

Dec 4, 2023 · Inovio Pharmaceuticals Inc (NASDAQ:INO) trade information. Sporting 0.96% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on Friday, 12/01/23 when the INO stock price touched $0.40 or saw a rise of 6.08%. Inovio Pharmaceuticals (INO) Company Description: Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA ...Inovio Pharmaceuticals Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Inovio Pharmaceuticals Inc. Quarterly; Annual; Actual Analyst Range Consensus. 0.10 0.00-0.10-0.20 ...Overview Stock Screener Earnings Calendar Sectors Nasdaq | INO U.S.: Nasdaq Inovio Pharmaceuticals Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 22, 2023 7:33 p.m....

Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Web

The latest price target for Inovio Pharmaceuticals ( NASDAQ: INO) was reported by RBC Capital on Thursday, May 11, 2023. The analyst firm set a price target for 2.00 expecting INO to rise to ...

4 Mar 2020 ... Shares of Inovio Pharmaceuticals Inc., the genetic vaccine company, hit a four-year high Wednesday, rising as much as 16% to $9.40 a share ...The latest price target for Inovio Pharmaceuticals ( NASDAQ: INO) was reported by RBC Capital on Thursday, May 11, 2023. The analyst firm set a price target for 2.00 expecting INO to rise to ... Trial achieved primary and secondary efficacy endpoints among all evaluable subjects in the Phase 3 multi-center, randomized, double-blind, placebo-controlled trial VGX-3100 is the first DNA medicine to achieve efficacy endpoints in a Phase 3 clinical trial INOVIO also continues to partner with QIAGEN to develop a pre-treatment predictive …WebINOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the European Commission (EC) has granted orphan drug designation for INO-3107, the company's product …INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA …WebAt Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Inovio Pharmaceuticals Inc. If you are looking for stocks with good return, Inovio Pharmaceuticals Inc stock can be a bad, high-risk 1-year investment option. Inovio Pharmaceuticals reported quarterly losses of 15 cents per share which beat the analyst consensus estimate of a loss of 30 cents. The company also reported quarterly sales of $9.15 million ...

Lead Case No. 2:20-cv-01962-GJP. NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER. DERIVATIVE ACTIONS. TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF INOVIO PHARMACEUTICALS, INC ...WebAs of December 31, 2022, INOVIO had 253.1 million common shares outstanding and 271.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.Inovio Pharmaceuticals saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 24,940,000 shares, a decline of 3.0% from the previous total of 25,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are ...1 Mei 2020 ... Inovio Pharmaceuticals' stock has climbed higher and higher over the past month since it said it was working on a speedy COVID-19 vaccine.Inovio Pharmaceuticals ( INO) reported Q3 2023 earnings per share (EPS) of -$0.13, meeting estimates of -$0.13 by 0.29%. In the same quarter last year, Inovio Pharmaceuticals 's earnings per share (EPS) was -$0.15. Inovio Pharmaceuticals is expected to release next earnings on 02/28/2024, with an earnings per share (EPS) …WebINO stock forecast for 2023 – 2027. Last updated: November 10, 2023. Inovio Pharmaceuticals, Inc. 0.3497 D 3.42% (0.0124)

Find the latest analyst research for Inovio Pharmaceuticals, Inc. Common Stock (INO) at Nasdaq.com.

Inovio Pharmaceuticals ' ( INO 4.66%) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its ...Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Aug 9, 2022 · As of June 30, 2022, INOVIO had 247.5 million shares of common stock outstanding and 267.8 million shares of common stock outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. if you purchased or acquired inovio pharmaceuticals, inc.(“inovio”) common stock from february 14, 2020 through august 10, 2020, inclusive (the “class”), you could receive a payment from a ...Find out the direct holders, institutional holders and mutual fund holders for Inovio Pharmaceuticals, Inc. (INO).Shares of Inovio Pharmaceuticals Inc. (INO) and Novavax Inc. (NVAX) took a hit on Wednesday as the companies failed to make it to the list of finalists for the Operation Warp Speed initiative. 2.WebThe stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month ...The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large 27% drop over the last ten ...

As of June 30, 2022, INOVIO had 247.5 million shares of common stock outstanding and 267.8 million shares of common stock outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.

These factors combined to bring our net loss for the second quarter of 2023 to $35.5 million or $0.13 per share basic and dilutive, compared to a net loss of $108.5 million or $0.46 per share ...

Today, let's take a closer look at clinical-stage biotech company Inovio Pharmaceuticals ( INO 4.66%) and see whether it has what it takes to join that select group of millionaire-maker stocks ...Track Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS ...Inovio Pharmaceuticals Inc. closed $1.59 below its 52-week high ($1.99), which the company reached on January 13th. The stock outperformed some of its competitors …See why we are neutral on INO stock. ... Jun. 27, 2023 7:15 AM ET Inovio Pharmaceuticals, Inc. (INO) 11 Comments 3 Likes. Out of Ignorance. 7.05K Followers. Follow. Summary.Jacqueline Shea, Ph.D. Dr. Jacqueline Shea has served as INOVIO’s President and Chief Executive Officer (CEO) since May 2022. She is responsible for establishing and leading INOVIO’s overall corporate strategy across its clinical programs and advancing its DNA medicines platform. Dr. Shea joined the Company in March 2019 as Chief Operating ...See why we are neutral on INO stock. ... Jun. 27, 2023 7:15 AM ET Inovio Pharmaceuticals, Inc. (INO) 11 Comments 3 Likes. Out of Ignorance. 7.05K Followers. Follow. Summary.INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Inovio Pharmaceuticals, Inc. 0.4014-0.0086 ... A stock sale "will shine a spotlight on the business model and financials" of the fast-fashion giant about which little is known, said one analyst. ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

J. Joseph Kim, co-founder and former CEO of Inovio Pharmaceuticals. ... Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38.On eToro, you can buy $INO or other stocks and pay ZERO commission! Follow Inovio Pharmaceuticals Inc share price and get more information. Terms apply.Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Instagram:https://instagram. soxl dividendtsingtao brewerycathie wood stock picksripster Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ... Inovio Pharmaceuticals Inc (NASDAQ:INO) 0.4291. Delayed Data. As of Nov 17 ... As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ... forrester research stockhow do you make money shorting a stock Inovio Pharmaceuticals ( INO) reported Q3 2023 earnings per share (EPS) of -$0.13, meeting estimates of -$0.13 by 0.29%. In the same quarter last year, Inovio Pharmaceuticals 's earnings per share (EPS) was -$0.15. Inovio Pharmaceuticals is expected to release next earnings on 02/28/2024, with an earnings per share (EPS) …WebAs of June 30, 2022, Inovio had 247.5 million shares of common stock outstanding and 267.8 million shares of common stock outstanding on a fully diluted basis. Total operating expenses were $104.9M. tcent stock Inovio Pharmaceuticals ... There's not much real hope left with this stock, so I'd advise closing your Inovio position or removing it from your watchlist and not waiting for it to recover. 2.WebResearch & Development Center. 10480 Wateridge Circle San Diego, CA 92121 Phone: 858-597-6006INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...Web